Literature DB >> 21273705

Application of RNA interference in treating human diseases.

S Abdolhamid Angaji1, Sara Sadate Hedayati, Reihane Hosein Poor, Safoura Madani, Sanaz Samad Poor, Samin Panahi.   

Abstract

Gene silencing can occur either through repression of transcription, termed transcriptional gene silencing (TGS), or through translation repression andmRNA degradation, termed posttranscriptional gene silencing (PTGS). PTGS results from sequence-specific mRNA degradation in the cytoplasm without dramatic changes in transcription of corresponding gene in nucleus. Both TGS and PTGS are used to regulate endogenous genes. Interestingly, mechanisms for gene silencing also protect the genome from transposons and viruses. In this paper, we first review RNAi mechanism and then focus on some of its applications in biomedical research such as treatment for HIV, viral hepatitis, cardiovascular and cerebrovascular diseases, metabolic disease, neurodegenerative disorders and cancer.

Entities:  

Mesh:

Year:  2010        PMID: 21273705     DOI: 10.1007/s12041-010-0073-3

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  110 in total

Review 1.  Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.

Authors:  A Migliazza; E Cayanis; F Bosch-Albareda; H Komatsu; S Martinotti; E Toniato; S Kalachikov; M F Bonaldo; P Jelene; X Ye; A Rzhetsky; X Qu; M Chien; G Inghirami; G Gaidano; U Vitolo; G Saglio; L Resegotti; P Zhang; M B Soares; J Russo; S G Fischer; I S Edelman; A Efstratiadis; R Dalla-Favera
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA.

Authors:  G Hutvágner; J McLachlan; A E Pasquinelli; E Bálint; T Tuschl; P D Zamore
Journal:  Science       Date:  2001-07-12       Impact factor: 47.728

3.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

Review 4.  Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?

Authors:  J Weiler; J Hunziker; J Hall
Journal:  Gene Ther       Date:  2006-03       Impact factor: 5.250

5.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

Review 6.  Lessons from animal models of Huntington's disease.

Authors:  David C Rubinsztein
Journal:  Trends Genet       Date:  2002-04       Impact factor: 11.639

7.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

8.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

9.  Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571).

Authors:  Lara Wohlbold; Heiko van der Kuip; Cornelius Miething; Hans-Peter Vornlocher; Cornelius Knabbe; Justus Duyster; Walter E Aulitzky
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

10.  Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).

Authors:  Christiane Nieth; Axel Priebsch; Alexandra Stege; Hermann Lage
Journal:  FEBS Lett       Date:  2003-06-19       Impact factor: 4.124

View more
  15 in total

1.  Lentivirus-mediated ADAM17 RNA interference inhibited interleukin-8 expression via EGFR signaling in lung epithelial cells.

Authors:  Yaqing Li; Jianping Yan; Wulin Xu; Hong Wang; Yingjie Xia
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 2.  RNA viruses and microRNAs: challenging discoveries for the 21st century.

Authors:  Gokul Swaminathan; Julio Martin-Garcia; Sonia Navas-Martin
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

Review 3.  Selection of RNAi-based inhibitors for anti-HIV gene therapy.

Authors:  Stefanie A Knoepfel; Mireille Centlivre; Ying Poi Liu; Fatima Boutimah; Ben Berkhout
Journal:  World J Virol       Date:  2012-06-12

Review 4.  Delivery and targeting of miRNAs for treating liver fibrosis.

Authors:  Virender Kumar; Ram I Mahato
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

5.  Sonoporation using microbubbles promotes lipofectamine-mediated siRNA transduction to rat retina.

Authors:  Xiaozhi Zheng; Ping Ji; Jianqun Hu
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

6.  Replacement of all arginine residues with canavanine in MazF-bs mRNA interferase changes its specificity.

Authors:  Yojiro Ishida; Jung-Ho Park; Lili Mao; Yoshihiro Yamaguchi; Masayori Inouye
Journal:  J Biol Chem       Date:  2013-02-01       Impact factor: 5.157

7.  MicroRNA expression signature in human abdominal aortic aneurysms.

Authors:  Matthew C Pahl; Kimberly Derr; Gabor Gäbel; Irene Hinterseher; James R Elmore; Charles M Schworer; Thomas C Peeler; David P Franklin; John L Gray; David J Carey; Gerard Tromp; Helena Kuivaniemi
Journal:  BMC Med Genomics       Date:  2012-06-15       Impact factor: 3.063

8.  VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA.

Authors:  Nishant Thakur; Abid Qureshi; Manoj Kumar
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

Review 9.  Progress and Prospects of Anti-HBV Gene Therapy Development.

Authors:  Mohube B Maepa; Ilke Roelofse; Abdullah Ely; Patrick Arbuthnot
Journal:  Int J Mol Sci       Date:  2015-07-31       Impact factor: 5.923

10.  A preliminary step of a novel strategy in suicide gene therapy with lentiviral vector.

Authors:  Jahan Afrooz Ghanbari; Mansoor Salehi; Arezoo Karam Zadeh; Sedigheh Momen Zadeh; Vahid Bahram Beigi; Hossein Khan Ahmad; Behzad Mahaki; Mina Beiraghdar
Journal:  Adv Biomed Res       Date:  2014-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.